A Collaborative Effort to Reimagine EDMD Care
cureEDMD brings together patients, researchers, clinicians, and investors to accelerate progress for people affected by Emery-Dreifuss muscular dystrophy.
What We’ve Accomplished Thus Far
cureEDMD was officially founded in 2025 by a family with lived experiences with EDMD. Even before the start of cureEDMD, the founders had raised over a million dollars for EDMD research.
Meet Us
Meet the people working together to advance treatments and cures for EDMD.

Ray Mills is the founder and president of cureEDMD and the parent of a son with EDMD. He earned a PhD from Stanford University, a master’s degree from the Massachusetts Institute of Technology, and a bachelor’s degree from Virginia Tech. Ray serves on the advisory board of the Fralin Biomedical Research Institute at Virginia Tech Carillion.
Laura Bordone is Director of Clinical Development at Ionis Pharmaceuticals, where she helps advance potential medicines through clinical research. Her work has included clinical studies and patient-focused research in hereditary angioedema, a rare disease. Before joining Ionis, she held research leadership roles at the Genomics Institute of the Novartis Research Foundation and the Novartis Institutes for BioMedical Research. Laura earned her PhD from the University of Minnesota and completed postdoctoral research at the Massachusetts Institute of Technology focused on the molecular mechanisms of aging and age-related disease.
Laura has a family member affected by EDMD and participates in cureEDMD researcher meetings, bringing both her drug-development expertise and her family perspective to the conversation.
Ann is a board-certified genetic counselor with more than 25 years of experience spanning pediatric genetics, hereditary cancer genetics, telehealth, genomic policy, genetics payment integrity, and clinical billing integrity. Throughout her career, Ann has been committed to helping patients and families understand complex genetic information and navigate their healthcare journeys. Her passion for rare disease advocacy extends beyond her professional work through volunteering with the Wisconsin Rare Disease Alliance and cureEDMD. She believes that listening to patients and families and building a connected, informed community are essential to advancing research and improving the lives of those affected by EDMD.
Walter Bircher is a robotics engineer and Member of Technical Staff at Microsoft, where he works on Physical AI. He earned a PhD in robotic manipulation at Yale University and previously developed robotic hardware at Amazon. Walter lives with EDMD and brings his technical background and personal perspective to cureEDMD. In his spare time, he loves international travel.
Monil Gandhi began volunteering with CureEDMD in 2026. He is an entrepreneur and investor with experience across varied industries and growth stages. He holds two Bachelor of Science degrees in Industrial Engineering and Manufacturing and Design Engineering from Northwestern University and an MBA from the University of Chicago Booth School of Business.
As an individual living with Emery-Dreifuss Muscular Dystrophy, Monil knows firsthand the challenges the condition presents across many aspects of his life. He is proud to support CureEDMD in its search for a treatment or cure.
In his free time, Monil loves to explore Chicago and travel to new cities with his wife and active young sons.
Gabriella Snyder is a second-year genetic counseling master's student at the Medical College of Wisconsin (MCW). She graduated from the University of Iowa in 2024 with a bachelor's of science in anthropology and biology.